Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Xiang Xia

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8476-7916; OpenAlex author ID A5101735363. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 5

  1. Erratum: Downregulation of miR-301a-3p sensitizes pancreatic cancer cells to gemcitabine treatment via PTEN. Co-author DOI 10.62347/vddd1924↗
  2. Synchronous primary colorectal mucinous adenocarcinoma and pancreatic ductal adenocarcinoma: A case report. Co-author DOI 10.3892/ol.2023.13991↗
  3. miR-301a plays a pivotal role in hypoxia-induced gemcitabine resistance in pancreatic cancer. First author DOI 10.1016/j.yexcr.2018.05.013↗
  4. Downregulation of miR-301a-3p sensitizes pancreatic cancer cells to gemcitabine treatment via PTEN. Co-author PMID 28469793↗
  5. MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4. Co-author DOI 10.18632/oncotarget.4124↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhengjun Qiu · 3 shared papers, 2015–2018 · strength 0.21
  2. Xudong Qiu · 1 shared paper, 2023 · strength 0.19
  3. Hui Cao · 1 shared paper, 2023 · strength 0.19
  4. Chunchao Zhu Zhu · 1 shared paper, 2023 · strength 0.19
  5. Bo Ni · 1 shared paper, 2023 · strength 0.19
  6. Guangtao Luo · 2 shared papers, 2017–2018 · strength 0.16
  7. Gang Cen · 2 shared papers, 2015–2017 · strength 0.13
  8. Chen Huang · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.